Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP eye drops for severe treatment-resistant dry eye disease
MOH_2024-09-02_013615Phase 3Not yet recruiting
- Sponsor
- ד"ר לירון ברקוביץ
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of platelet-rich plasma in dry eye syndrome (DED), sponsored by ד"ר לירון ברקוביץ. Primary endpoints: Change in corneal staining and Change in Ocular Surface Disease Index score. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on MOH_2024-09-02_013615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-09-02_013615.